{{Rsnum
|rsid=1045241
|Gene=TNFAIP8
|Chromosome=5
|position=119393591
|Orientation=plus
|GMAF=0.2489
|Gene_s=TNFAIP8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 53.1 | 40.7 | 6.2
| HCB | 69.3 | 29.2 | 1.5
| JPT | 76.1 | 23.9 | 0.0
| YRI | 39.0 | 47.3 | 13.7
| ASW | 45.6 | 47.4 | 7.0
| CHB | 69.3 | 29.2 | 1.5
| CHD | 70.6 | 23.9 | 5.5
| GIH | 52.5 | 38.6 | 8.9
| LWK | 47.3 | 41.8 | 10.9
| MEX | 56.9 | 37.9 | 5.2
| MKK | 40.4 | 43.6 | 16.0
| TSI | 65.7 | 27.5 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22666399
|Title=Tumor Necrosis Factor-α Induced Protein 8 Polymorphism and Risk of Non-Hodgkin's Lymphoma in a Chinese Population: A Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=23840460
|Title=Lymphotoxin Alpha (LTA) Polymorphism Is Associated with Prognosis of Non-Hodgkin's Lymphoma in a Chinese Population
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}